Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Signs Up Quebec Distributor for H1N1 Test

NEW YORK (GenomeWeb News) – Warnex has signed up Biron Laboratoire medical, a diagnostic and medical services provider in Quebec, to distribute its test for influenza A H1N1, Warnex said yesterday.

Warnex said Biron, which operates more than 100 sites throughout Quebec, will promote and distribute the test and will specifically target industrial companies as customers.

The Warnex test uses RT-PCR to detect the A H1N1 strain in as little as eight hours, the company said.

"With the possibility of a significant incidence rate of the pandemic A H1N1 flu virus this fall, companies are increasingly concerned with the effect this might have on their workforce," Warnex CEO and President Mark Busgang said in a statement.

Busgang also said that the diagnostic test will enable employees to receive diagnosis earlier, "allowing company decision makers to rapidly take appropriate action to limit the spread of infection to the rest of the workforce."

Terms of the agreement were not disclosed.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.